Literature DB >> 29675695

[Dyspnea after instillation therapy for bladder cancer].

D Julius1, H F Geerdes Fenge2, M-A Weber3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29675695     DOI： 10.1007/s00117-018-0382-8

Source DB:  PubMed          Journal:  Radiologe        ISSN： 0033-832X            Impact factor:   0.635


× No keyword cloud information.
  10 in total

1.  [Miliary induced by intravesical BCG immunotherapy for carcinoma of the bladder: CT Findings].

Authors:  F Mignon; A Chevrière; B Mesurolle; M El Hajam; H Morel; P Lacombe
Journal:  J Radiol       Date:  2002-03

2.  [Rare pulmonary complication in intravesical BCG treatment].

Authors:  C Audigier; P Nesme; M Perol; J C Guerin
Journal:  Rev Mal Respir       Date:  2000-06       Impact factor: 0.622

3.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

4.  Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.

Authors:  Vladimir Novotny; Michael Froehner; Johanna Ollig; Rainer Koch; Stefan Zastrow; Manfred P Wirth
Journal:  Urol Int       Date:  2016-01-21       Impact factor: 2.089

5.  [BCGitis with Involvement of Lung, Liver and Bone Marrow after Immunotherapy of Urothelial Cancer].

Authors:  Hilte Friederike Geerdes-Fenge; Franziska Stubbe; Micha Löbermann; Philipp Warnke; Andreas Erbersdobler; Emil Christian Reisinger
Journal:  Dtsch Med Wochenschr       Date:  2017-09-08       Impact factor: 0.628

Review 6.  Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin.

Authors:  J K Izes; W Bihrle; C B Thomas
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

7.  Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG.

Authors:  Maurizio Brausi; Jorg Oddens; Richard Sylvester; Aldo Bono; Cees van de Beek; George van Andel; Paolo Gontero; Levent Turkeri; Sandrine Marreaud; Sandra Collette; Willem Oosterlinck
Journal:  Eur Urol       Date:  2013-07-24       Impact factor: 20.096

8.  Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy.

Authors:  C McParland; D J Cotton; K S Gowda; V H Hoeppner; W T Martin; P F Weckworth
Journal:  Am Rev Respir Dis       Date:  1992-11

9.  Bone marrow infection with bacillus Calmette-Guérin (BCG) after intravesical immunotherapy.

Authors:  Johannes Nemeth; Brigitte Stoiser; Heide-Maria Winkler; Leonard Müllauer; Wolfgang Graninger; Stefan Winkler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

10.  Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy.

Authors:  Kyohei Kaburaki; Keishi Sugino; Muneyuki Sekiya; Yujiro Takai; Kazutoshi Shibuya; Sakae Homma
Journal:  Intern Med       Date:  2017-06-15       Impact factor: 1.271
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.